Endo Cert Bid Calls AGs' Use Of Private Attys Unconstitutional

Law360, Washington (November 9, 2017, 10:50 PM EST) -- Drugmaker Endo Pharmaceuticals has asked the U.S. Supreme Court to bar states from using outside “contingency-fee” lawyers to investigate and litigate allegations of fraudulent marketing practices by makers of opioid painkillers, saying state governments’ reliance on outside, profit-motivated counsel violates its due process rights.

Endo, which in July pulled from the market its Opana ER painkiller amid concerns it was prone to abuse, asked the high court to overturn a New Hampshire Supreme Court ruling that upheld a contract for Motley Rice LLC’s Linda Singer to investigate Endo...
To view the full article, register now.